Immunotherapy for Squamous Non-Small Cell Lung Cancer episode artwork

EPISODE · Jun 11, 2015 · 8 MIN

Immunotherapy for Squamous Non-Small Cell Lung Cancer

from GRACEcast · host cancerGRACE Meetings

Research released at the 2015 American Society of Clinical Oncology (ASCO) annual meeting showed great promise for squamous cell lung cancer patients taking the immunotherapy drug Opdivo (nivolumab). But can we predict which patients will do well on it?

Episode metadata supplied by the publisher feed · Published Jun 11, 2015

Embed this episode

NOW PLAYING

Immunotherapy for Squamous Non-Small Cell Lung Cancer

0:00 8:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 8 minutes long.

When was this GRACEcast episode published?

This episode was published on June 11, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!